Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.
- Published In:
- Frontiers in immunology, 16, 1542380 (2025)
- Authors:
- Wang, Shu-Hung, Serr, Isabelle, Digigow, Reinaldo, Metzler, Barbara, Surnov, Alexey, Gottwick, Cornelia, Alsamman, Muhammad, Krzikalla, Daria, Heine, Markus, Zahlten, Miriam, Widera, Agata, Mungalpara, Disha, Şeleci, Muharrem, Fanzutti, Marco, Marques Mesquita, Lígia Margarida, Vocaturo, Anna-Lisa, Herkel, Johannes, Carambia, Antonella, Schröter, Christian, Sarko, Dikran, Pohlner, Johannes, Daniel, Carolin, de Min, Cristina, Fleischer, Sabine
- Database ID:
- RPEP-14041
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14041APA
Wang, Shu-Hung; Serr, Isabelle; Digigow, Reinaldo; Metzler, Barbara; Surnov, Alexey; Gottwick, Cornelia; Alsamman, Muhammad; Krzikalla, Daria; Heine, Markus; Zahlten, Miriam; Widera, Agata; Mungalpara, Disha; Şeleci, Muharrem; Fanzutti, Marco; Marques Mesquita, Lígia Margarida; Vocaturo, Anna-Lisa; Herkel, Johannes; Carambia, Antonella; Schröter, Christian; Sarko, Dikran; Pohlner, Johannes; Daniel, Carolin; de Min, Cristina; Fleischer, Sabine. (2025). Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.. Frontiers in immunology, 16, 1542380. https://doi.org/10.3389/fimmu.2025.1542380
MLA
Wang, Shu-Hung, et al. "Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.." Frontiers in immunology, 2025. https://doi.org/10.3389/fimmu.2025.1542380
RethinkPeptides
RethinkPeptides Research Database. "Nanoparticle platform preferentially targeting liver sinusoi..." RPEP-14041. Retrieved from https://rethinkpeptides.com/research/wang-2025-nanoparticle-platform-preferentially-targeting
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.